Point72 »

Apogee Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 19k 58.74
2024-06-30 $660k 17k 39.35

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
BlackRock
Driehaus Capital Management
Fairmount Funds Management
Perceptive Advisors
Vanguard Group
RA Capital Management
Braidwell
State Street Corporation
Alliancebernstein
Deep Track Capital
Woodline Partners
Franklin Resources
Geode Capital Management

View all funds holding Apogee Therapeutics